Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRAVO
NCT07903350Phase 4Recruiting
- Sponsor
- Illumina
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 4 trial of Ebola Zaire vaccine (live, attenuated) in Bundibugyo virus disease (BVD), sponsored by Illumina. Started Sep 2026; status: recruiting.
02
Drugs
Ebola Zaire vaccine (live, attenuated)
03
Conditions
Bundibugyo virus disease (BVD)
Beyond the preview
Go deeper on NCT07903350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07903350.